Car Dashboards
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Cannabis-based Medicines Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CBD (Cannabidiol) Based
1.2.3 THC (Tetrahydrocannabinol) Based
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cannabis-based Medicines Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cannabis-based Medicines Market Perspective (2017-2028)
2.2 Cannabis-based Medicines Growth Trends by Region
2.2.1 Cannabis-based Medicines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cannabis-based Medicines Historic Market Size by Region (2017-2022)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Region (2023-2028)
2.3 Cannabis-based Medicines Market Dynamics
2.3.1 Cannabis-based Medicines Industry Trends
2.3.2 Cannabis-based Medicines Market Drivers
2.3.3 Cannabis-based Medicines Market Challenges
2.3.4 Cannabis-based Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cannabis-based Medicines Players by Revenue
3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2017-2022)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2017-2022)
3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
3.4 Global Cannabis-based Medicines Market Concentration Ratio
3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2021
3.5 Cannabis-based Medicines Key Players Head office and Area Served
3.6 Key Players Cannabis-based Medicines Product Solution and Service
3.7 Date of Enter into Cannabis-based Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis-based Medicines Breakdown Data by Type
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2017-2022)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2023-2028)
5 Cannabis-based Medicines Breakdown Data by Application
5.1 Global Cannabis-based Medicines Historic Market Size by Application (2017-2022)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cannabis-based Medicines Market Size (2017-2028)
6.2 North America Cannabis-based Medicines Market Size by Country (2017-2022)
6.3 North America Cannabis-based Medicines Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2017-2028)
7.2 Europe Cannabis-based Medicines Market Size by Country (2017-2022)
7.3 Europe Cannabis-based Medicines Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cannabis-based Medicines Market Size (2017-2028)
8.2 Asia-Pacific Cannabis-based Medicines Market Size by Country (2017-2022)
8.3 Asia-Pacific Cannabis-based Medicines Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cannabis-based Medicines Market Size (2017-2028)
9.2 Latin America Cannabis-based Medicines Market Size by Country (2017-2022)
9.3 Latin America Cannabis-based Medicines Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cannabis-based Medicines Market Size (2017-2028)
10.2 Middle East & Africa Cannabis-based Medicines Market Size by Country (2017-2022)
10.3 Middle East & Africa Cannabis-based Medicines Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Detail
11.1.2 GW Pharmaceuticals plc Business Overview
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2017-2022)
11.1.5 GW Pharmaceuticals plc Recent Development
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Detail
11.2.2 INSYS Therapeutics Business Overview
11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022)
11.2.5 INSYS Therapeutics Recent Development
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Detail
11.3.2 Aequus Pharmaceuticals Business Overview
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.3.5 Aequus Pharmaceuticals Recent Development
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Detail
11.4.2 Axim Biotechnologies Business Overview
11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2017-2022)
11.4.5 Axim Biotechnologies Recent Development
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Detail
11.5.2 Revive Therapeutics Business Overview
11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022)
11.5.5 Revive Therapeutics Recent Development
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Detail
11.6.2 MGC Pharmaceuticals Business Overview
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.6.5 MGC Pharmaceuticals Recent Development
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Detail
11.7.2 ECHO Pharmaceuticals Business Overview
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022)
11.7.5 ECHO Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of CBD (Cannabidiol) Based
Table 3. Key Players of THC (Tetrahydrocannabinol) Based
Table 4. Key Players of Others
Table 5. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cannabis-based Medicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cannabis-based Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cannabis-based Medicines Market Share by Region (2017-2022)
Table 9. Global Cannabis-based Medicines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cannabis-based Medicines Market Share by Region (2023-2028)
Table 11. Cannabis-based Medicines Market Trends
Table 12. Cannabis-based Medicines Market Drivers
Table 13. Cannabis-based Medicines Market Challenges
Table 14. Cannabis-based Medicines Market Restraints
Table 15. Global Cannabis-based Medicines Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cannabis-based Medicines Market Share by Players (2017-2022)
Table 17. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis-based Medicines as of 2021)
Table 18. Ranking of Global Top Cannabis-based Medicines Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cannabis-based Medicines Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cannabis-based Medicines Product Solution and Service
Table 22. Date of Enter into Cannabis-based Medicines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cannabis-based Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cannabis-based Medicines Revenue Market Share by Type (2017-2022)
Table 26. Global Cannabis-based Medicines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cannabis-based Medicines Revenue Market Share by Type (2023-2028)
Table 28. Global Cannabis-based Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cannabis-based Medicines Revenue Market Share by Application (2017-2022)
Table 30. Global Cannabis-based Medicines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cannabis-based Medicines Revenue Market Share by Application (2023-2028)
Table 32. North America Cannabis-based Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Cannabis-based Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Cannabis-based Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Cannabis-based Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Cannabis-based Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Cannabis-based Medicines Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Cannabis-based Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Cannabis-based Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Cannabis-based Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Cannabis-based Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 42. GW Pharmaceuticals plc Company Detail
Table 43. GW Pharmaceuticals plc Business Overview
Table 44. GW Pharmaceuticals plc Cannabis-based Medicines Product
Table 45. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 46. GW Pharmaceuticals plc Recent Development
Table 47. INSYS Therapeutics Company Detail
Table 48. INSYS Therapeutics Business Overview
Table 49. INSYS Therapeutics Cannabis-based Medicines Product
Table 50. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 51. INSYS Therapeutics Recent Development
Table 52. Aequus Pharmaceuticals Company Detail
Table 53. Aequus Pharmaceuticals Business Overview
Table 54. Aequus Pharmaceuticals Cannabis-based Medicines Product
Table 55. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 56. Aequus Pharmaceuticals Recent Development
Table 57. Axim Biotechnologies Company Detail
Table 58. Axim Biotechnologies Business Overview
Table 59. Axim Biotechnologies Cannabis-based Medicines Product
Table 60. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 61. Axim Biotechnologies Recent Development
Table 62. Revive Therapeutics Company Detail
Table 63. Revive Therapeutics Business Overview
Table 64. Revive Therapeutics Cannabis-based Medicines Product
Table 65. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 66. Revive Therapeutics Recent Development
Table 67. MGC Pharmaceuticals Company Detail
Table 68. MGC Pharmaceuticals Business Overview
Table 69. MGC Pharmaceuticals Cannabis-based Medicines Product
Table 70. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 71. MGC Pharmaceuticals Recent Development
Table 72. ECHO Pharmaceuticals Company Detail
Table 73. ECHO Pharmaceuticals Business Overview
Table 74. ECHO Pharmaceuticals Cannabis-based Medicines Product
Table 75. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2017-2022) & (US$ Million)
Table 76. ECHO Pharmaceuticals Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabis-based Medicines Market Share by Type: 2021 VS 2028
Figure 2. CBD (Cannabidiol) Based Features
Figure 3. THC (Tetrahydrocannabinol) Based Features
Figure 4. Others Features
Figure 5. Global Cannabis-based Medicines Market Share by Application in 2021 & 2028
Figure 6. Oral Solution Case Studies
Figure 7. Tablets Case Studies
Figure 8. Patches Case Studies
Figure 9. Others Case Studies
Figure 10. Cannabis-based Medicines Report Years Considered
Figure 11. Global Cannabis-based Medicines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cannabis-based Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cannabis-based Medicines Market Share by Region: 2021 VS 2028
Figure 14. Global Cannabis-based Medicines Market Share by Players in 2021
Figure 15. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis-based Medicines as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2021
Figure 17. North America Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Cannabis-based Medicines Market Share by Country (2017-2028)
Figure 19. United States Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Cannabis-based Medicines Market Share by Country (2017-2028)
Figure 23. Germany Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cannabis-based Medicines Market Share by Region (2017-2028)
Figure 31. China Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Cannabis-based Medicines Market Share by Country (2017-2028)
Figure 39. Mexico Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Cannabis-based Medicines Market Share by Country (2017-2028)
Figure 43. Turkey Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Cannabis-based Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 46. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 47. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 48. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 49. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 50. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 51. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GW Pharmaceuticals plc INSYS Therapeutics Aequus Pharmaceuticals Axim Biotechnologies Revive Therapeutics MGC Pharmaceuticals ECHO Pharmaceuticals